Floatz logo

Brexpiprazole

Schizophrenia

Humanis Saglık Anonim SirketiSmall moleculePhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
81/ 100
Competitive Position
65/ 100

Competitive context

141 Active assets in the Schizophrenia cohort.

Asset / SponsorPhaseRating
TROSPIUM
European Group for Research In Schizophrenia
Phase 4BBB
Xanomeline
European Group for Research In Schizophrenia
Phase 4BBB
Lurasidone
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase 4BBB
Asenapine
Noven Pharmaceuticals, Inc.
Phase 4BBB
Bitopertin
Hoffmann-La Roche
Phase 3BBB

View all 50 →

Same molecule, other indications

Brexpiprazole is also rated in:

depressive disorderActive
A
Indicative · Phase 4
82 / 100
View asset →
major depressive disorderActive
BBB
Indicative · Phase 4
75 / 100
View asset →
mood disorderDormant
BBB
Indicative · Phase 3
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →